These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11918465)

  • 1. Using the new antiepilepsy drugs in children.
    Wheless JW
    J Child Neurol; 2002 Jan; 17 Suppl 1():S58-64. PubMed ID: 11918465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three new drugs for epilepsy: levetiracetam, oxcarbazepine, and zonisamide.
    Leppik IE
    J Child Neurol; 2002 Jan; 17 Suppl 1():S53-7. PubMed ID: 11918464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new antiepileptic drugs.
    Macleod S; Appleton RE
    Arch Dis Child Educ Pract Ed; 2007 Dec; 92(6):182-8. PubMed ID: 18032714
    [No Abstract]   [Full Text] [Related]  

  • 4. Newer therapies in the drug treatment of epilepsy.
    McAuley JW; Biederman TS; Smith JC; Moore JL
    Ann Pharmacother; 2002 Jan; 36(1):119-29. PubMed ID: 11816240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review.
    Marson AG; Hutton JL; Leach JP; Castillo S; Schmidt D; White S; Chaisewikul R; Privitera M; Chadwick DW
    Epilepsy Res; 2001 Sep; 46(3):259-70. PubMed ID: 11518627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two new drugs for epilepsy.
    Med Lett Drugs Ther; 2000 Apr; 42(1076):33-5. PubMed ID: 10803174
    [No Abstract]   [Full Text] [Related]  

  • 7. The new antiepileptic drugs: scientific review.
    LaRoche SM; Helmers SL
    JAMA; 2004 Feb; 291(5):605-14. PubMed ID: 14762040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
    Epilepsia; 2004 May; 45(5):410-23. PubMed ID: 15101822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxcarbazepine, topiramate, zonisamide, and levetiracetam: potential use in neuropathic pain.
    Guay DR
    Am J Geriatr Pharmacother; 2003 Sep; 1(1):18-37. PubMed ID: 15555463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel anticonvulsant drugs.
    Stefan H; Feuerstein TJ
    Pharmacol Ther; 2007 Jan; 113(1):165-83. PubMed ID: 17030393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epilepsy treatment in adults and adolescents: Expert opinion, 2016.
    Shih JJ; Whitlock JB; Chimato N; Vargas E; Karceski SC; Frank RD
    Epilepsy Behav; 2017 Apr; 69():186-222. PubMed ID: 28237319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
    Epilepsia; 2004 May; 45(5):401-9. PubMed ID: 15101821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New antiepileptic drugs in pediatric epilepsy.
    Hwang H; Kim KJ
    Brain Dev; 2008 Oct; 30(9):549-55. PubMed ID: 18328657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New antiepileptic drugs].
    Rouvel-Tallec A
    Rev Med Interne; 2009 Apr; 30(4):335-9. PubMed ID: 19195742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New anticonvulsants for use in pediatric patients (part I).
    Kopec K
    J Pediatr Health Care; 2001; 15(2):81-6; quiz 87-8. PubMed ID: 11246198
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinically relevant reduction of lamotrigine concentrations by carbamazepine.
    Koch HJ; Szecsey A; Vogel M
    Eur Psychiatry; 2003 Feb; 18(1):42. PubMed ID: 12648898
    [No Abstract]   [Full Text] [Related]  

  • 17. Levetiracetam in refractory pediatric epilepsy.
    Wheless JW; Ng YT
    J Child Neurol; 2002 Jun; 17(6):413-5. PubMed ID: 12174960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come?
    Perucca E; Johannessen SI
    Epileptic Disord; 2003 May; 5 Suppl 1():S17-26. PubMed ID: 12915337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis.
    Luszczki JJ; Andres MM; Czuczwar P; Cioczek-Czuczwar A; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2006 Jan; 47(1):10-20. PubMed ID: 16417526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zonisamide monotherapy for epilepsy in children and young adults.
    Wilfong AA
    Pediatr Neurol; 2005 Feb; 32(2):77-80. PubMed ID: 15664764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.